Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Statins and primary prevention: is all the evidence in?

× No keyword cloud information.

19 in total

1. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors:
Journal: JAMA Date: 2001-05-16 Impact factor: 56.272

Review 2. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver.

Authors: Jay D Horton; Joseph L Goldstein; Michael S Brown
Journal: J Clin Invest Date: 2002-05 Impact factor: 14.808

Review 3. Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal.

Authors: James H O'Keefe; Loren Cordain; William H Harris; Richard M Moe; Robert Vogel
Journal: J Am Coll Cardiol Date: 2004-06-02 Impact factor: 24.094

4. Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease.

Authors: Ruth McPherson; Jiri Frohlich; George Fodor; Jacques Genest
Journal: Can J Cardiol Date: 2006-09 Impact factor: 5.223

5. Biomedicine. Lowering LDL--not only how low, but how long?

Authors: Michael S Brown; Joseph L Goldstein
Journal: Science Date: 2006-03-24 Impact factor: 47.728

Review 6. Should cholesterol-lowering medications be available in Canada without a prescription?

Authors: Shirya Rashid
Journal: Can J Cardiol Date: 2007-03-01 Impact factor: 5.223

7. Familial HDL deficiency characterized by hypercatabolism of mature apoA-I but not proapoA-I.

Authors: R Batal; M Tremblay; L Krimbou; O Mamer; J Davignon; J Genest; J S Cohn
Journal: Arterioscler Thromb Vasc Biol Date: 1998-04 Impact factor: 8.311

8. Mortality by cause for eight regions of the world: Global Burden of Disease Study.

Authors: C J Murray; A D Lopez
Journal: Lancet Date: 1997-05-03 Impact factor: 79.321

Review 9. The epidemiologic basis for population-wide cholesterol reduction in the primary prevention of coronary artery disease.

Authors: Thomas A Pearson
Journal: Am J Cardiol Date: 2004-11-04 Impact factor: 2.778

Review 10. Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part V: the discovery of the statins and the end of the controversy.

Authors: Daniel Steinberg
Journal: J Lipid Res Date: 2006-04-03 Impact factor: 5.922

1 in total

1. Statin-prescribing trends for primary and secondary prevention of cardiovascular disease.

Authors: Felicity Brown; Alexander Singer; Alan Katz; Gerald Konrad
Journal: Can Fam Physician Date: 2017-11-14 Impact factor: 3.275

1 in total